Evidence map›Paper›PMID 35955669›Full record

ArticleInternational journal of molecular sciences2022

Pharmacological and In Silico Analysis of Oat Avenanthramides as EGFR Inhibitors: Effects on EGF-Induced Lung Cancer Cell Growth and Migration.

Lorenza Trabalzini, Jasmine Ercoli, Alfonso Trezza, Irene Schiavo, Giulia Macrì, Andrea Moglia, Ottavia Spiga, Federica Finetti

Open access · goldAbstract read
In one paragraph

Article in International journal of molecular sciences, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
1.5field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 17 citations in OpenAlex.

  1. Review
  2. Review
  3. A Study of the Fruits ofAntioxidants (Basel, Switzerland) · 2025
    Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. In vitro Digestion ofFoods (Basel, Switzerland) · 2023
    Article
  10. Review
  11. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

Lorenza TrabalziniDepartment of Biotechnology, Chemistry and Pharmacy, University of Siena, 53100 Siena, Italy.ORCID 0000-0002-0850-7186
Jasmine ErcoliDepartment of Biotechnology, Chemistry and Pharmacy, University of Siena, 53100 Siena, Italy.
Alfonso TrezzaDepartment of Biotechnology, Chemistry and Pharmacy, University of Siena, 53100 Siena, Italy.
Irene SchiavoDepartment of Biotechnology, Chemistry and Pharmacy, University of Siena, 53100 Siena, Italy.
Giulia MacrìDepartment of Biotechnology, Chemistry and Pharmacy, University of Siena, 53100 Siena, Italy.
Andrea MogliaDepartment of Agriculture, Forest and Food Sciences, Plant Genetics and Breeding, University of Torino, 10095 Torino, Italy.ORCID 0000-0001-7431-844X
Ottavia SpigaDepartment of Biotechnology, Chemistry and Pharmacy, University of Siena, 53100 Siena, Italy.
Federica FinettiDepartment of Biotechnology, Chemistry and Pharmacy, University of Siena, 53100 Siena, Italy.ORCID 0000-0003-1144-3360
University of Siena · ITUniversity of Turin · IT

Funding

Ministry of Education, Universities and Research Progetto Dipartimento di Eccellenza 2018-2022
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

AvenaLung NeoplasmsCell Line, TumorEdible GrainEpidermal Growth FactorErbB ReceptorsHumansortho-AminobenzoatesProtein Kinase Inhibitorsavenanthramide-2CEGFR protein, humanEpidermal Growth FactorErbB Receptorsortho-AminobenzoatesProtein Kinase Inhibitorsavenanthramide Cavenanthramidesclassical molecular dynamics simulationdocking simulationEGFRlung cancersteered molecular dynamics simulation

Identifiers

PMID35955669
PMCPMC9369115
OpenAlexW4289315852

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.